Advertisement

Pharmaceutisch weekblad

, Volume 3, Issue 1, pp 1325–1335 | Cite as

The bioavailability of seven commercially available rectal aminophylline suppositories

  • J. J. Tukker
  • J. P. Crombeen
  • D. D. Breimer
  • C. J. De Blaey
Article

Abstract

The bioavailability and thein vitro parameters of seven aminophylline 360 mg suppositories were compared with an oral hydroalcoholic solution of aminophylline as reference, using cross-over designs in groups of four subjects in single dose experiments. Plasma concentrations were followed for eight hours after drug administration. Four products gave extents of bioavailability of less than 80% of the reference solution. A dissolution test gave results which did not correlate well with the bioavailability results. It was concluded that no satisfactory plasma levels can be reached with the examined dose of aminophylline after single administration of one suppository.

Calculation of the steady-state concentration was performed as well as a graphic simulation of the plasma concentration-time curves, after repeated administration; it was demonstrated that with most of the suppositories no sufficiently high level could be obtained after three doses per day.

Keywords

Theophylline Aminophylline Theobromine Melting Time Graphic Simulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blaey, C.J. De, andA.G. De Boer (1976)Pharm. Weekblad 111, 1216–1221.Google Scholar
  2. Blaey, C.J. De, andJ.J. Rutten-Kingma (1976)Pharm. Act. Helv. 51, 186–192;Ibidem (1977) 52, 11–14.Google Scholar
  3. Breimer, D.D. (1976)Pharm. Weekblad 111, 1221–1236.Google Scholar
  4. British Pharmacopoeia (1980) University Press, Cambridge, England.Google Scholar
  5. Brower, J.F., E.C. Juenge, D.P. Page andH.L. Dow (1980)J. Pharm. Sci. 69, 942–945.CrossRefPubMedGoogle Scholar
  6. Dutch Pharmacopoeia (1978) ed. VIII. Staatsuitgeverij, The Hague, The Netherlands.Google Scholar
  7. European Pharmacopoeia (1975) ed. 1, Vol. III Maisonneuve S.A., Sainte Ruffine, France.Google Scholar
  8. Hendeles, L., M. Weinberger andL. Bighley (1977)Am. J. Hosp. Pharm. 34, 525–527.PubMedGoogle Scholar
  9. Krówczynski, L. (1959)Dissertationes Pharm. 269.Google Scholar
  10. Mcgilveray, I.J., K.K. Midha andJ.K. Cooper (1978b)Can. J. Pharm. Sci. 13, 33–39.Google Scholar
  11. Mcgilveray, I.J., K.K. Midha andJ.K. Cooper (1978b)Can. J. Pharm. Sci. 13, 9–11.Google Scholar
  12. Moolenaar, F., andH.L.M. Cox (1980)Pharm. Weekblad 115, 585–587.CrossRefGoogle Scholar
  13. Ogilvie, R.I. (1978)Clin. Pharmacokin. 3, 267–293.CrossRefGoogle Scholar
  14. Riegelman, S., andR.A. Upton (1979) In:Drug Absorption (Prescott, L.F., andW.S. Nimmo, Eds.).Adis Press, Sidney, 297.Google Scholar
  15. Stuurman-Bieze, A.G.G., A.J.M. Schoonen, A. Fens, V.D. Heuy, L.M. Peeters-Udding andT. Huizinga (1980)Pharm. Weekblad Sci. Ed. 2, 172–179.Google Scholar
  16. Sved, S., andD.L. Wilson (1977)Res. Comm. Chem. Pathol. Pharmacol. 17, 319–331.Google Scholar
  17. Tukker, J.J., andC.J. De Blaey (1981) In preparation.Google Scholar
  18. Wagner, J., andE. Nelson (1963)J. Pharm. Sci. 52, 610–611.CrossRefPubMedGoogle Scholar
  19. Zuidema, J. (1978) Ph.D. Thesis, Amsterdam, The Netherlands.Google Scholar

Copyright information

© Bohn, Scheltema & Holkema 1981

Authors and Affiliations

  • J. J. Tukker
    • 1
  • J. P. Crombeen
    • 1
  • D. D. Breimer
    • 2
  • C. J. De Blaey
    • 1
  1. 1.Department of PharmaceuticsState University of UtrechtGH UtrechtThe Netherlands
  2. 2.Department of PharmacologyState University of LeidenRA LeidenThe Netherlands

Personalised recommendations